| 2026-08-06 | 10-Q | 10.6 | Lease Amendment No. 3, dated April 1, 2026, by and among Corbus Pharmaceuticals, Inc., Corbus Pharmaceuticals Holdings, Inc. and River Ridge Limited Partnership.* |
|---|
| 2026-07-06 | 8-K | 10.1 | Employment Agreement, dated July 2, 2026, between Corbus Pharmaceuticals Holdings, Inc. and Leonardo Viana Nicacio, MD. |
|---|
| 2026-05-21 | 8-K | 10.1 | Employment Agreement, dated May 21, 2026, between Corbus Pharmaceuticals Holdings, Inc. and Nishant Saxena. |
|---|
| 2026-05-14 | 8-K | 10.1 | Amendment to the Corbus Pharmaceuticals Holdings, Inc. 2024 Equity Compensation Plan. |
|---|
| 2026-04-16 | 8-K | 10.2 | Form of Seventh Amended and Restated Employment Agreement between Corbus Pharmaceuticals Holdings, Inc. and Sean Moran. |
|---|
| 2026-04-16 | 8-K | 10.1 | Form of Sixth Amended and Restated Employment Agreement between Corbus Pharmaceuticals Holdings, Inc. and Yuval Cohen. |
|---|
| 2025-03-18 | 8-K | 10.1 | Service Agreement between Corbus International Limited and Ian Hodgson, effective as of March 15, 2025. |
|---|
| 2024-05-20 | 8-K | 10.5 | Form of Restricted Stock Unit Award Agreement. |
|---|
| 2024-05-20 | 8-K | 10.4 | Form of Restricted Stock Award Agreement. |
|---|
| 2024-05-20 | 8-K | 10.3 | Form of Non-Statutory Stock Option Grant Agreement. |
|---|
| 2024-05-20 | 8-K | 10.2 | Form of Incentive Stock Option Grant Agreement. |
|---|
| 2024-05-20 | 8-K | 10.1 | Corbus Pharmaceuticals Holdings, Inc. 2024 Equity Compensation Plan. |
|---|
| 2024-04-10 | 8-K | 10.2 | Form of Sixth Amended and Restated Employment Agreement between Corbus Pharmaceuticals Holdings, Inc. and Sean Moran. |
|---|
| 2024-04-10 | 8-K | 10.1 | Form of Fifth Amended and Restated Employment Agreement between Corbus Pharmaceuticals Holdings, Inc. and Yuval Cohen. |
|---|
| 2024-03-12 | 10-K | 10.33 | Form of Service Agreement between Corbus International Limited and Dominic Smethurst, dated February 27, 2024. |
|---|
| 2023-04-24 | 8-K/A | 10.1 | Separation and General Release Agreement between the Company and Craig Millian, dated April 24, 2023. |
|---|
| 2023-03-07 | 10-K | 10.29 | License Agreement between the Company and CSPC Megalith Biopharmaceutical Co., Ltd.* |
|---|
| 2022-10-31 | 8-K | 10.1 | Amendment to Loan Agreement. |
|---|
| 2022-04-15 | 8-K | 10.3 | Form of Second Amended and Restated Employment Agreement between Corbus Pharmaceuticals Holdings, Inc. and Craig Millian. |
|---|
| 2022-04-15 | 8-K | 10.2 | Form of Fifth Amended and Restated Employment Agreement between Corbus Pharmaceuticals Holdings, Inc. and Sean Moran. |
|---|
| 2022-04-15 | 8-K | 10.1 | Form of Fourth Amended and Restated Employment Agreement between Corbus Pharmaceuticals Holdings, Inc. and Yuval Cohen. |
|---|
| 2022-03-08 | 10-K | 10.31 | Employment Agreement between the Company and Rachael Brake, effective as of December 6, 2021. †* |
|---|
| 2021-09-28 | 8-K | 10.1 | Amendment to Employment Agreement between Corbus Pharmaceuticals Holdings, Inc., and Craig Millian, effective as of September 27, 2021. |
|---|
| 2021-09-22 | 8-K/A | 10.1 | Separation and General Release Agreement between the Company and Barbara White, dated September 17, 2021. |
|---|
| 2021-08-12 | 10-Q | 10.2 | License Agreement, dated May 26, 2021, between Corbus Pharmaceuticals, Inc. and The Regents of the University of California.*# |
|---|
| 2021-08-12 | 10-Q | 10.1 | License Agreement, dated May 25, 2021, between Corbus Pharmaceuticals, Inc. and Milky Way BioPharma, LLC.*# |
|---|
| 2020-12-04 | 8-K/A | 10.1 | Separation and Release Agreement between the Company and Robert Discordia, dated November 30, 2020. |
|---|
| 2020-07-29 | 8-K | 10.1 | Loan and Security Agreement, dated as of July 28, 2020, by and between Corbus Pharmaceuticals Holdings, Inc., Corbus Pharmaceuticals, Inc., K2 Healthventures LLC and Ankura Trust Company, LLC. |
|---|
| 2020-05-11 | 10-Q | 10.5 | Amended and Restated Employment Agreement between Corbus Pharmaceuticals Holdings, Inc. and Robert Discordia, effective as of April 11, 2020.* |
|---|
| 2020-05-11 | 10-Q | 10.4 | Amended and Restated Employment Agreement between Corbus Pharmaceuticals Holdings, Inc. and Craig Millian, effective as of April 11, 2020.* |
|---|
| 2020-05-11 | 10-Q | 10.3 | Fourth Amended and Restated Employment Agreement between Corbus Pharmaceuticals Holdings, Inc. and Sean Moran, effective as of April 11, 2020.* |
|---|
| 2020-05-11 | 10-Q | 10.2 | Second Amended and Restated Employment Agreement between Corbus Pharmaceuticals Holdings, Inc. and Barbara White, effective as of April 11, 2020.* |
|---|
| 2020-05-11 | 10-Q | 10.1 | Third Amended and Restated Employment Agreement between Corbus Pharmaceuticals Holdings, Inc. and Yuval Cohen, effective as of April 11, 2020.* |
|---|
| 2020-04-01 | 8-K | 10.3 | Form of Third Amended and Restated Employment Agreement between Corbus Pharmaceuticals Holdings, Inc. and Sean Moran. |
|---|
| 2020-04-01 | 8-K | 10.2 | Form of Second Amended and Restated Employment Agreement between Corbus Pharmaceuticals Holdings, Inc. and Barbara White. |
|---|
| 2020-04-01 | 8-K | 10.1 | Form of Second Amended and Restated Employment Agreement between Corbus Pharmaceuticals Holdings, Inc. and Yuval Cohen. |
|---|
| 2019-11-07 | 10-Q | 10.1 | Lease Amendment No. 2 dated as of October 25, 2019, among River Ridge Limited Partnership, Corbus Pharmaceuticals, Inc. and Corbus Pharmaceuticals Holdings, Inc.* |
|---|
| 2019-04-01 | 8-K | 10.2 | Consulting Agreement between Corbus Pharmaceutical Holdings, Inc. and Mark Tepper, dated March 31, 2019. |
|---|
| 2019-04-01 | 8-K | 10.1 | Separation Agreement between Corbus Pharmaceutical Holdings, Inc. and Mark Tepper, dated March 31, 2019. |
|---|
| 2019-03-12 | 10-K | 10.41 | Offer Letter, dated as of February 19, 2019, between Craig Millian and Corbus Pharmaceuticals, Inc.* |
|---|
| 2019-03-12 | 10-K | 10.40 | Lease Amendment No. 1, dated as of February 26, 2019, among River Ridge Limited Partnership, Corbus Pharmaceuticals, Inc. and Corbus Pharmaceuticals Holdings, Inc.* |
|---|
| 2019-01-03 | 8-K | 10.1 | Collaboration and License Agreement, dated January 3, 2019, between Corbus Pharmaceuticals, Inc. and Kaken Pharmaceutical Co., Ltd.# |
|---|
| 2018-11-08 | 10-Q | 10.1 | License Agreement, dated as of September 20, 2018, between Corbus Pharmaceuticals, Inc. and Jenrin Discovery, LLC.#*. |
|---|
| 2018-04-13 | 8-K | 10.4 | Amended and Restated Employment Agreement between Corbus Pharmaceuticals Holdings, Inc. and Sean Moran, dated April 11, 2018. |
|---|
| 2018-04-13 | 8-K | 10.3 | Amended and Restated Employment Agreement between Corbus Pharmaceuticals Holdings, Inc. and Barbara White, dated April 11, 2018. |
|---|
| 2018-04-13 | 8-K | 10.2 | Amended and Restated Employment Agreement between Corbus Pharmaceuticals Holdings, Inc. and Mark Tepper, dated April 11, 2018. |
|---|
| 2018-04-13 | 8-K | 10.1 | Amended and Restated Employment Agreement between Corbus Pharmaceuticals Holdings, Inc. and Yuval Cohen, dated April 11, 2018. |
|---|
| 2018-03-12 | 10-K | 10.33 | Cystic Fibrosis Program Related Investment Agreement, dated January 26, 2018, between Cystic Fibrosis Foundation Therapeutics, Inc. and the Company.#* |
|---|
| 2017-08-22 | 8-K | 10.2 | Guarantee, dated August 21, 2017, by Corbus Pharmaceuticals Holdings, Inc. |
|---|
| 2017-08-22 | 8-K | 10.1 | Lease Agreement, dated August 21, 2017, by and between Corbus Pharmaceuticals, Inc. and River Ridge Limited Partnership. |
|---|
| 2017-02-28 | 8-K | 10.1 | Securities Purchase Agreement, dated February 28, 2017 between Corbus Pharmaceuticals Holdings, Inc. and certain investors |
|---|
| 2016-11-10 | 10-Q | 10.5 | Third Amendment to Lease Agreement dated May 30, 2014, dated September 13, 2016, by and between the Company and River Ridge Limited Partnership. |
|---|
| 2016-11-10 | 10-Q | 10.4 | Second Amendment to Lease Agreement dated May 30, 2014, dated March 30, 2016, by and between the Company and River Ridge Limited Partnership. |
|---|
| 2016-11-10 | 10-Q | 10.3 | First Amendment to Lease Agreement dated May 30, 2014, dated August 27, 2015, by and between the Company and River Ridge Limited Partnership. |
|---|
| 2016-11-10 | 10-Q | 10.2 | Lease Agreement, dated May 30, 2014, by and between the Company and River Ridge Limited Partnership. |
|---|
| 2016-09-21 | 8-K | 10.1 | Consulting Agreement, dated September 20, 2016, by and between the Company and Orchestra |
|---|
| 2016-06-10 | 8-K | 10.1 | Securities Purchase Agreement, dated June 10, 2016. between Corbus Pharmaceuticals Holdings, Inc. and certain investors |
|---|
| 2016-04-15 | 8-K | 10.4 | Employment Agreement between Corbus Pharmaceuticals Holdings, Inc. and Barbara White, dated April 11, 2016. |
|---|
| 2016-04-15 | 8-K | 10.3 | Amendment No. 1 to Amended and Restated Employment Agreement between Corbus Pharmaceuticals Holdings, Inc. and Sean Moran, dated April 11, 2016. |
|---|
| 2016-04-15 | 8-K | 10.2 | Amendment No. 1 to Employment Agreement between Corbus Pharmaceuticals Holdings, Inc. and Mark Tepper, dated April 11, 2016. |
|---|
| 2016-04-15 | 8-K | 10.1 | Amendment No. 1 to Employment Agreement between Corbus Pharmaceuticals Holdings, Inc. and Yuval Cohen, dated April 11, 2016. |
|---|
| 2015-05-13 | 10-Q | 10.1 | Award Agreement, dated April 9, 2015, between Cystic Fibrosis Foundation Therapeutics, Inc. and the Company.*# |
|---|